CIK 1597549
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2017-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 54.98% | 35 |
| Pharmaceuticals & Biotechnology | 35.68% | 20 |
| Insurance | 6.45% | 2 |
| Health Care Equipment & Supplies | 1.95% | 1 |
| Life Sciences Tools & Services | 0.94% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ESPR | Esperion Therapeutics, Inc. | Health Care | 5.44% |
| 2 | IMMUNOMEDICS INC | Unclassified | 4.39% | |
| 3 | GLOBAL BLOOD THERAPEUTICS INC | Unclassified | 4.18% | |
| 4 | HUM | HUMANA INC | Financials | 4.04% |
| 5 | BIIB | BIOGEN INC. | Health Care | 3.60% |
| 6 | MRK | Merck & Co., Inc. | Health Care | 3.28% |
| 7 | ARENA PHARMECEUTICALS INC | Unclassified | 2.97% | |
| 8 | SHIRE PLC | Unclassified | 2.81% | |
| 9 | CLOVIS ONCOLOGY INC | Unclassified | 2.78% | |
| 10 | ANAB | ANAPTYSBIO, INC | Health Care | 2.54% |
24/59 names classified · sector 45.0% of weight · industry 45.0% · mkt cap 45.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 45.0% of the book is sector-classified (unclassified names shown, never dropped).
Only 21% of book weight classified — the grid is NOT representative of the whole book.
Classified: 21.0% of book weight (9/27 names) · unclassified 79.0%: , ESPR, ANAB, CNC, RARE, SGMOQ, RCKT, CTMX, IOVA, KPTI +8 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ESPRESPERION THERAPEUTICS INC NE | 100,000 | $7M | 5.4% | TRIM −39% |
| 2 | IMMUNOMEDICS INC | 400,000 | $6M | 4.4% | TRIM −11% |
| 3 | GLOBAL BLOOD THERAPEUTICS INC | 115,000 | $6M | 4.2% | TRIM −8% |
| 4 | HUMHUMANA INC | 20,000 | $5M | 4.0% | TRIM −11% |
| 5 | BIIBBIOGEN INC | 17,500 | $5M | 3.6% | TRIM −20% |
| 6 | MRKMERCK & CO INC | 80,000 | $4M | 3.3% | HOLD |
| 7 | ARENA PHARMECEUTICALS INC | 100,000 | $4M | 3.0% | ADD 100% |
| 8 | SHIRE PLC | 25,000 | $4M | 2.8% | NEW |
| 9 | CLOVIS ONCOLOGY INC | 70,000 | $4M | 2.8% | ADD 17% |
| 10 | ANABANAPTYSBIO INC | 32,500 | $3M | 2.5% | TRIM −19% |
| 11 | CIGNA CORPORATION | 20,000 | $3M | 2.5% | TRIM −20% |
| 12 | MYLAN NV | 80,000 | $3M | 2.5% | ADD 100% |
| 13 | CNCCENTENE CORP DEL | 30,000 | $3M | 2.4% | NEW |
| 14 | BMYBRISTOL-MYERS SQUIBB CO | 50,000 | $3M | 2.4% | HOLD |
| 15 | ALEXION PHARMACEUTICALS INC | 27,500 | $3M | 2.3% | NEW |
| 16 | RAREULTRAGENYX PHARMACEUTICAL IN | 60,000 | $3M | 2.3% | ADD 20% |
| 17 | ABTABBOTT LABS | 50,000 | $3M | 2.3% | TRIM −33% |
| 18 | LABORATORY CORP AMER HLDGS | 17,500 | $3M | 2.1% | NEW |
| 19 | ADMAADMA BIOLOGICS INC | 600,000 | $3M | 2.1% | HOLD |
| 20 | DXCMDEXCOM | 35,000 | $3M | 2.0% | NEW |
| 21 | CATALYST BIOSCIENCES INC | 100,000 | $3M | 1.9% | NEW |
| 22 | TESARO INC. | 45,000 | $3M | 1.9% | ADD 29% |
| 23 | ZOSANO PHARMA CORP | 500,000 | $3M | 1.9% | NEW |
| 24 | SGMOQSANGAMO THERAPEUTICS INC | 125,000 | $2M | 1.8% | TRIM −17% |
| 25 | GLAXOSMITHKLINE PLC | 60,000 | $2M | 1.8% | ADD 100% |
| 26 | RCKTROCKET PHARMACEUTICALS INC | 125,000 | $2M | 1.8% | NEW |
| 27 | MEDICINES CO | 70,000 | $2M | 1.7% | ADD 17% |
| 28 | Armo Biosciences Inc | 60,000 | $2M | 1.7% | NEW |
| 29 | SIERRA ONCOLOGY INC | 1,000,000 | $2M | 1.6% | ADD 25% |
| 30 | DIPLOMAT PHARMACY INC | 100,000 | $2M | 1.5% | ADD 100% |
| 31 | MYOKARDIA INC | 40,000 | $2M | 1.5% | TRIM −20% |
| 32 | CTMXCYTOMX THERAPEUTICS INC. | 65,000 | $2M | 1.4% | TRIM −13% |
| 33 | IOVAIOVANCE BIOTHERAPEUTICS INC | 100,000 | $2M | 1.3% | NEW |
| 34 | MIRATI THERAPEUTICS INC | 55,000 | $2M | 1.3% | NEW |
| 35 | KPTIKARYOPHARM THERAPEUTICS INC | 125,000 | $2M | 1.3% | TRIM −58% |
| 36 | VKTXVIKING THERAPEUTICS INC | 375,000 | $2M | 1.2% | ADD 67% |
| 37 | ARWRARROWHEAD PHARMACEUTICALS IN | 200,000 | $1M | 1.1% | NEW |
| 38 | MERUS N V | 75,000 | $1M | 1.0% | TRIM −25% |
| 39 | VYGRVOYAGER THERAPEUTICS INC | 70,000 | $1M | 1.0% | ADD 40% |
| 40 | ACHAOGEN INC | 100,000 | $1M | 1.0% | ADD 33% |
| 41 | CORIUM INTL INC | 110,000 | $1M | 0.9% | ADD 22% |
| 42 | INCYINCYTE CORP | 15,000 | $1M | 0.9% | ADD 50% |
| 43 | CATALENT INC | 30,000 | $1M | 0.9% | HOLD |
| 44 | Adverum Biotechnologies, Inc. | 200,000 | $1M | 0.9% | HOLD |
| 45 | CERNER CORP | 20,000 | $1M | 0.9% | NEW |
| 46 | XNCRXENCOR INC | 35,000 | $1M | 0.8% | NEW |
| 47 | KURAKURA ONCOLOGY INC | 50,000 | $938,000 | 0.7% | NEW |
| 48 | SEATTLE GENETICS INC | 17,500 | $916,000 | 0.7% | NEW |
| 49 | SPECTRUM PHARMACEUTICALS INC | 50,000 | $805,000 | 0.6% | NEW |
| 50 | DERMIRA INC | 100,000 | $799,000 | 0.6% | HOLD |
| 51 | ASMBASSEMBLY BIOSCIENCES INC | 15,000 | $737,000 | 0.6% | NEW |
| 52 | ADAMAS PHARMACEUTICALS INC | 30,000 | $717,000 | 0.5% | NEW |
| 53 | EXELEXELIXIS INC | 30,000 | $665,000 | 0.5% | NEW |
| 54 | AFFIMED N V | 300,000 | $555,000 | 0.4% | NEW |
| 55 | SCYXSCYNEXIS INC COM NEW | 400,000 | $536,000 | 0.4% | ADD 60% |
| 56 | ONCOMED PHARMACEUTICALS INC | 150,000 | $477,000 | 0.4% | HOLD |
| 57 | K2M GROUP HLDGS INC | 25,000 | $474,000 | 0.4% | TRIM −86% |
| 58 | MARINUS PHARMACEUTICALS INC | 100,000 | $382,000 | 0.3% | HOLD |
| 59 | SLDBSOLID BIOSCIENCES INC COM NEW | 50,000 | $375,000 | 0.3% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
